Literature DB >> 7621010

Oral epithelial dysplasia and the development of invasive squamous cell carcinoma.

H Lumerman1, P Freedman, S Kerpel.   

Abstract

Oral epithelial dysplasia, the histopathologic marker of a premalignant disorder of the mouth mucosa, may present clinically as leukoplakia, erythroplakia, or leukoerythroplakia. Its presence in lesions of the oral mucosa is predictive by a variable rate (6.6% to 36%) of transformation to invasive squamous cell carcinoma. We studied the clinical features and microscopic slides of 308 case of oral epithelial dysplasia in our biopsy service and retrospectively evaluated 44 of these with follow-up data for transformation to invasive squamous cell carcinoma. Forty-four patients had follow-up of more than 6 months with a mean follow-up time of 18.4 months. Twenty (45%) were clinically free of disease and 15 (34%) had recurrence of the dysplasia. An additional two cases of lower grades of the disease recurred as carcinoma in situ. Invasive squamous cell carcinoma developed in seven (16%) in a mean transformation time of 33.6 months.

Entities:  

Mesh:

Year:  1995        PMID: 7621010     DOI: 10.1016/s1079-2104(05)80226-4

Source DB:  PubMed          Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod        ISSN: 1079-2104


  82 in total

1.  ACP Best Practice No 157. Guidelines for the laboratory handling of laryngectomy specimens.

Authors:  T R Helliwell
Journal:  J Clin Pathol       Date:  2000-03       Impact factor: 3.411

2.  Overexpression of Smad proteins, especially Smad7, in oral epithelial dysplasias.

Authors:  Yuk-Kwan Chen; Anderson Hsien-Cheng Huang; Pei-Hsun Cheng; Shang-Hsun Yang; Li-Min Lin
Journal:  Clin Oral Investig       Date:  2012-06-06       Impact factor: 3.573

3.  DAPK promoter hypermethylation in tissues and body fluids of oral precancer patients.

Authors:  Yang Liu; Zeng-Tong Zhou; Qing-Bo He; Wei-Wen Jiang
Journal:  Med Oncol       Date:  2011-04-24       Impact factor: 3.064

4.  Clinicopathological parameters, recurrence, locoregional and distant metastasis in 115 T1-T2 oral squamous cell carcinoma patients.

Authors:  Waseem Jerjes; Tahwinder Upile; Aviva Petrie; Andrew Riskalla; Zaid Hamdoon; Michael Vourvachis; Kostas Karavidas; Amrita Jay; Ann Sandison; Gareth J Thomas; Nicholas Kalavrezos; Colin Hopper
Journal:  Head Neck Oncol       Date:  2010-04-20

5.  The Self-Reported Knowledge, Attitude and the Practices Regarding the Early Detection of Oral Cancer and Precancerous Lesions among the Practising Dentists of Dakshina Kannada-A Pilot Study.

Authors:  Shaila M; Pushparaj Shetty; Audrey Madonna Decruz; Prakash Pai
Journal:  J Clin Diagn Res       Date:  2013-07-01

6.  Loss of BCL-2 in the progression of oral cancer is not attributable to mutations.

Authors:  L L Loro; A C Johannessen; O K Vintermyr
Journal:  J Clin Pathol       Date:  2005-11       Impact factor: 3.411

7.  Smoking and drinking in relation to oral cancer and oral epithelial dysplasia.

Authors:  Douglas E Morse; Walter J Psoter; Deborah Cleveland; Donald Cohen; Mireseyed Mohit-Tabatabai; Diane L Kosis; Ellen Eisenberg
Journal:  Cancer Causes Control       Date:  2007-07-24       Impact factor: 2.506

8.  Histological and immunohistochemical evaluation of new epithelium after removal of oral leukoplakia with Nd:YAG laser treatment.

Authors:  Lucio Montebugnoli; Francesca Frini; Davide Bartolomeo Gissi; Andrea Gabusi; Fabio Cervellati; Maria Pia Foschini; Claudio Marchetti
Journal:  Lasers Med Sci       Date:  2011-06-18       Impact factor: 3.161

9.  Screening the pathogenic genes and pathways related to DMBA (7,12-dimethylbenz[a]anthracene)-induced transformation of hamster oral mucosa from precancerous lesions to squamous cell carcinoma.

Authors:  Dan Chen; Kai Yang; Jie Mei; Guodong Zhang; Xiaoqiang Lv; Li Xiang
Journal:  Oncol Lett       Date:  2011-04-26       Impact factor: 2.967

Review 10.  Grading systems in head and neck dysplasia: their prognostic value, weaknesses and utility.

Authors:  Stijn Fleskens; Piet Slootweg
Journal:  Head Neck Oncol       Date:  2009-05-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.